Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastasesPUBT·1 hour ago
Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectivesPUBT·21 hours agoCNXU+2.15%
argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the MovementTradingKey·1 day ago, 11:16 AMARGX+0.52%
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business UpdateUnusual Whales·Aug 14 at 06:01 AM
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.Barchart Option·Aug 12 at 12:11 PMACHV+0.27%
CERO THERAPEUTICS HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 19, 2025 at 03:12 PMCEROW0.00%
CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/2029 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -61.71Earnings Watch·Aug 22, 2025 at 03:08 PMCEROW0.00%
CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/2029 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -1.59Earnings Watch·May 15, 2025 at 03:59 PMCEROW0.00%
